{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T04:07:10Z","timestamp":1744258030529,"version":"3.40.4"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T00:00:00Z","timestamp":1674259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T00:00:00Z","timestamp":1674259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s10620-022-07785-1","type":"journal-article","created":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T02:27:22Z","timestamp":1674268042000},"page":"380-384","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Opportunistic Knocks: A Gardener with Ulcerative Colitis and New Pulmonary Nodules"],"prefix":"10.1007","volume":"68","author":[{"given":"Andrew","family":"Canakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sindhura","family":"Kolachana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Van K.","family":"Holden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond K.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,21]]},"reference":[{"issue":"4","key":"7785_CR1","doi-asserted-by":"publisher","first-page":"455","DOI":"10.5009\/gnl16308","volume":"11","author":"KH Katsanos","year":"2017","unstructured":"Katsanos KH, Papadakis KA. Inflammatory bowel disease: updates on molecular targets for biologics. Gut Liver. 2017;11:455\u2013463. https:\/\/doi.org\/10.5009\/gnl16308.","journal-title":"Gut Liver."},{"issue":"9","key":"7785_CR2","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/ajg.2012.218","volume":"107","author":"GR Lichtenstein","year":"2012","unstructured":"Lichtenstein GR, Feagan BG, Cohen RD et al. Serious infection and mortality in patients with Crohn\u2019s disease: more than 5 years of follow-up in the TREAT\u2122 registry. Am J Gastroenterol. 2012;107:1409\u20131422. https:\/\/doi.org\/10.1038\/ajg.2012.218.","journal-title":"Am J Gastroenterol."},{"key":"7785_CR3","doi-asserted-by":"publisher","unstructured":"Mushtaq K, Khan Z, Aziz M, et al. Trends and outcomes of fungal infections in hospitalized patients of inflammatory bowel disease: a nationwide analysis. Transl Gastroenterol Hepatol. 2020;5:35. https:\/\/doi.org\/10.21037\/tgh.2019.10.14","DOI":"10.21037\/tgh.2019.10.14"},{"issue":"1","key":"7785_CR4","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/MIB.0b013e3182a827d2","volume":"20","author":"M Dave","year":"2014","unstructured":"Dave M, Purohit T, Razonable R, Loftus EV. Opportunistic infections due to inflammatory bowel disease therapy. Inflamm Bowel Dis. 2014;20:196\u2013212. https:\/\/doi.org\/10.1097\/MIB.0b013e3182a827d2.","journal-title":"Inflamm Bowel Dis."},{"issue":"2","key":"7785_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1055\/s-2004-824898","volume":"25","author":"LJ Wheat","year":"2004","unstructured":"Wheat LJ, Conces D, Allen SD, Blue-Hnidy D, Loyd J. Pulmonary histoplasmosis syndromes: recognition, diagnosis, and management. Semin Respir Crit Care Med. 2004;25:129\u2013144. https:\/\/doi.org\/10.1055\/s-2004-824898.","journal-title":"Semin Respir Crit Care Med."},{"issue":"3","key":"7785_CR6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.diagmicrobio.2006.01.015","volume":"55","author":"M Assi","year":"2006","unstructured":"Assi M, McKinsey DS, Driks MR et al. Gastrointestinal histoplasmosis in the acquired immunodeficiency syndrome: report of 18 cases and literature review. Diagn Microbiol Infect Dis. 2006;55:195\u2013201. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2006.01.015.","journal-title":"Diagn Microbiol Infect Dis."},{"issue":"1","key":"7785_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4253\/wjge.v13.i1.24","volume":"13","author":"D Dahiya","year":"2021","unstructured":"Dahiya D, Kichloo A, Singh J, Albosta M, Wani F. Histoplasmosis and inflammatory bowel disease: a case report. World J Gastrointest Endosc. 2021;13:24\u201332. https:\/\/doi.org\/10.4253\/wjge.v13.i1.24.","journal-title":"World J Gastrointest Endosc."},{"issue":"6","key":"7785_CR8","first-page":"461","volume":"3","author":"G Psarros","year":"2007","unstructured":"Psarros G, Kauffman CA. Colonic histoplasmosis. Gastroenterol Hepatol. 2007;3:461\u2013463.","journal-title":"Gastroenterol Hepatol."},{"issue":"Suppl 3","key":"7785_CR9","doi-asserted-by":"publisher","first-page":"S194","DOI":"10.1086\/429996","volume":"41","author":"RS Wallis","year":"2005","unstructured":"Wallis RS, Broder M, Wong J, Lee A, Hoq L. Reactivation of latent granulomatous infections by infliximab. Clin Infect Dis Off Publ Infect Dis Soc Am. 2005;41:S194-198. https:\/\/doi.org\/10.1086\/429996.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am."},{"issue":"1","key":"7785_CR10","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s10620-020-06181-x","volume":"66","author":"CL Jansson-Knodell","year":"2021","unstructured":"Jansson-Knodell CL, Harris CE, Loftus EV, Walker RC, Enzler MJ, Virk A. Histoplasmosis in inflammatory bowel disease with tumor necrosis factor-alpha inhibitors: safe to continue biologics? Dig Dis Sci. 2021;66:190\u2013198. https:\/\/doi.org\/10.1007\/s10620-020-06181-x.","journal-title":"Dig Dis Sci."},{"issue":"3","key":"7785_CR11","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/cid\/civ299","volume":"61","author":"P Vergidis","year":"2015","unstructured":"Vergidis P, Avery RK, Wheat LJ et al. Histoplasmosis complicating tumor necrosis factor-\u03b1 blocker therapy: a retrospective analysis of 98 cases. Clin Infect Dis Off Publ Infect Dis Soc Am. 2015;61:409\u2013417. https:\/\/doi.org\/10.1093\/cid\/civ299.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07785-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-022-07785-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07785-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:04:34Z","timestamp":1744171474000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-022-07785-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,21]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["7785"],"URL":"https:\/\/doi.org\/10.1007\/s10620-022-07785-1","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"type":"print","value":"0163-2116"},{"type":"electronic","value":"1573-2568"}],"subject":[],"published":{"date-parts":[[2023,1,21]]},"assertion":[{"value":"5 December 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Raymond K. Cross has received income from consulting and participation in advisory boards for Abbvie, Adiso, BMS, Fresenius Kabi, Janssen, Magellan Health, Pfizer, and Samsung Bioepis. Drs. Canakis, Kolachana, and Holden declare no relevant funding.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}